A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

被引：0
|
作者：
Martin-Antonio, Beatriz
Suarez-LLedo, Maria
Arroyes, Montserrat
Fernandez-Aviles, Francesc [1 ]
Martinez, Carmen
Rovira, Montserrat
Espigado, Ildefonso [2 ]
Gallardo, David [3 ]
Bosch, Anna [4 ]
Buno, Ismael [5 ]
Martinez-Laperche, Carolina [6 ]
Jimenez-Velasco, Antonio [7 ]
De La Camara, Rafael [8 ]
Brunet, Salut [9 ]
Nieto, Jose B. [10 ]
Urbano-Ispizua, Alvaro [11 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] ICO Hosp Josep Trueta, Girona, Spain
[4] Hosp Josep Trueta, Girona, Spain
[5] Gregorio Maranon Hlth Res Inst IISGM, Madrid, Spain
[6] Gregorio Maranon Gen Univ Hosp, Dept Hematol, Madrid, Spain
[7] Hosp Carlos Haya, Malaga, Spain
[8] Hosp Univ De La Princesa, Madrid, Spain
[9] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[10] Hosp Morales Meseguer, Murcia, Spain
[11] IDIBAPS, Hosp Clin, Inst Hematol & Oncol, Barcelona, Spain
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.468.468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
468
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT
    Martin-Antonio, B.
    Suarez-Lledo, M.
    Arroyes, M.
    Fernandez-Aviles, F.
    Martinez, C.
    Rovira, M.
    Espigado, I.
    Gallardo, D.
    Bosch, A.
    Buno, I.
    Martinez-Laperche, C.
    Jimenez-Velasco, A.
    de la Camara, R.
    Brunet, S.
    Nieto, J. B.
    Urbano-Ispizua, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 (09) : 1205 - 1211
  • [2] A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT
    B Martín-Antonio
    M Suarez-Lledo
    M Arroyes
    F Fernández-Avilés
    C Martínez
    M Rovira
    I Espigado
    D Gallardo
    A Bosch
    I Buño
    C Martínez-Laperche
    A Jiménez-Velasco
    R de la Cámara
    S Brunet
    J B Nieto
    Á Urbano-Ispizua
    Bone Marrow Transplantation, 2013, 48 : 1205 - 1211
  • [3] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Siddhartha Ganguly
    Manik Amin
    Clint Divine
    Omar S. Aljitawi
    Sunil Abhyankar
    Joseph P. McGuirk
    Annals of Hematology, 2013, 92 : 549 - 550
  • [4] Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)
    Ganguly, Siddhartha
    Amin, Manik
    Divine, Clint
    Aljitawi, Omar S.
    Abhyankar, Sunil
    McGuirk, Joseph P.
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 549 - 550
  • [5] Allogeneic Stem Cell Transplantation (allo-SCT) for Secondary Acute Myeloid Leukemia (AML) Following Breast Carcinoma.
    Ayari, Sameh
    Mohty, Mohamad
    Bilger, Karin
    Guillerm, Gaelle
    Guyotat, Denis
    Michallet, Mauricette
    Ifrah, Norbert
    Chevallier, Patrice
    BLOOD, 2009, 114 (22) : 1281 - 1282
  • [6] Cure by chemotherapy without allogeneic stem cell transplantation (ALLO-SCT) in pediatric relapsed acute myeloid leukemia (AML)?
    Kaspers, G. J. L.
    Goemans, B. F.
    Korbijn, C.
    Tamminga, R. Y.
    Hahlen, K.
    ANNALS OF HEMATOLOGY, 2008, 87 : S3 - S3
  • [7] RUNX1 Mutation is Associated with Poor Outcome in Patients with Acute Myeloid Leukemia (AML) who Received Allogeneic Stem Cell Transplantation (allo-SCT)
    Chan, Onyee
    Jennings, Michelle
    Asghari, Hannah
    Song, Jinming
    Hussaini, Mohammad
    Sallman, David
    Padron, Eric
    Komrokji, Rami
    List, Alan
    Lancet, Jeffrey
    Mishra, Asmita
    Sweet, Kendra
    Talati, Chetasi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S233 - S233
  • [8] ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN THE ELDERLY PATIENTS (AGE > 65 YEARS) WITH ACUTE MYELOID LEUKEMIA (AML) IS SAFE AND EFFECTIVE
    Jagadeesh, D.
    Cerny, J.
    Ramanathan, M.
    Raffel, G. D.
    Petrillo-Deluca, L.
    Tarrasky, N.
    Krumpe, L. M.
    Bednarik, J.
    Barton, B. A.
    Walsh, W., V
    Nath, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S292 - S292
  • [9] Allogeneic stem cell transplantation (allo-SCT) in patients with advanced-phase acute leukemia
    Michalakeas, I
    Baltathakis, I
    Karakasis, D
    Delistrati, V
    Poulopoulou, Z
    Bika, E
    Skandalis, A
    Harhalakis, N
    Nikiforakis, E
    BONE MARROW TRANSPLANTATION, 2002, 29 : S81 - S81
  • [10] EFFECTS OF CHANGES IN CONDITIONING REGIMEN AND SUPPORTIVE CARE ON OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT)
    Abello, V
    Rosales, C.
    Pedraza, E.
    Linares, A.
    Esguerra, H.
    Rosales, M.
    Figueroa, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S232 - S232
12345